Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

Burandt, E; Jens, G; Holst, F; Jänicke, F; Müller, V; Quaas, A; Choschzick, M; Wilczak, W; Terracciano, L; Simon, R; Sauter, G; Lebeau, A

Burandt, E; Jens, G; Holst, F; Jänicke, F; Müller, V; Quaas, A; Choschzick, M; Wilczak, W; Terracciano, L; Simon, R; Sauter, G; Lebeau, A.

Affiliation

Burandt E; Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany. e.burandt@uke.de

Breast Cancer Res Treat ; 137(3): 745-53, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23322234

Subject(s)

Breast Neoplasms/metabolism; Nuclear Receptor Coactivator 3/metabolism; Adult; Aged; Aged, 80 and over; Breast Neoplasms/genetics; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Female; Gene Amplification; Gene Dosage; Gene Expression; Humans; Ki-67 Antigen/metabolism; Middle Aged; Nuclear Receptor Coactivator 3/genetics; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Nuclear Receptor Coactivator 3 Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2013 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google